Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Periferní vaskulární kalcifikace u hemodialyzovaných pacientů
[Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences]

Jean G, Bresson E, Errat JC, et al.

. 2009 ; 7 (3) : 38.

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07526716

Vascular calcifications (VCs) are frequently observed in chronic kidney disease (CKD) and haemodialysis (HD) patients. They have been associated with numerous factors, particularly hyperphosphataemia, excess calcium load, hypertension and increased mortality rate. The purpose of this study is to measure VCs in long-HD patients with good blood pressure and phosphate control, with the occasional use of sevelamer, using a plain radiological score to identify the associated factors and effects on the 1-year survival rate. METHODS: We studied HD patients from one centre using a semi-quantitative score ranging from 0 to 3 according to the severity and extent of VCs. The following patients' characteristics were compared according to their VC scores: medical history, treatments, blood pressure, standard biological data, fibroblast growth factor (FGF) 23, osteoprotegerin (OPG), whole PTH, beta-crosslaps, bone alkaline phosphatases and bone mineral density scores. One-year survival analyses were also performed. RESULTS: Among the 250 HD patients of the centre, 161 were studied; the mean age was 67.2 +/- 13 years, 45% of the subjects were females, 35% were diabetics, and they had been on dialysis for between 1-486 months (median: 45 months) with a 3 x 5-3 x 8 h dialysis schedule using 1.5 mmol/l dialysate calcium and providing a mean 2.25 +/- 0.5 Kt/V. Only 17% of the patients were free from VCs and 11% had severe VCs. The factors associated with VCs were classified into 'classic' (age, diabetes, male gender, tobacco use, inflammation, more frequent warfarin treatment and peripheral vascular and cardiac diseases) and 'non-traditional' (higher FGF-23 and OPG serum levels, low albumin serum levels and low alfacalcidol and CaCO(3) use). In logistic regression, only age, diabetes and FGF-23 serum levels were associated with VC scores of 2 and 3. The patients with a score of 3 had a higher 1-year mortality rate (RR 2.1; P = 0.01) as compared to patients with a 0 score. CONCLUSION: A plain radiological score showed the high prevalence (83%) of VCs in HD patients in spite of a long and intensive dialysis strategy and adherence to guidelines. The main associated factors were classic factors such as ageing and diabetes. No relationship was found with blood pressure and phosphataemia that remained well controlled in long dialysis; the association with FGF-23 serum levels may aggregate some non-traditional risk factors. The harmful effects of VCs on survival require their systematic assessment and optimization of the potentially modifiable associated factors in CKD and HD patients.

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

000      
00000naa 2200000 a 4500
001      
bmc07526716
003      
CZ-PrNML
005      
20111210143434.0
008      
090730s2009 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Jean, G.
245    10
$a Periferní vaskulární kalcifikace u hemodialyzovaných pacientů / $c Jean G, Bresson E, Errat JC, et al.
246    11
$a Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences
314    __
$a Centre de Rein Artificiel, Tassin la Demi-lune guillaume-jean-crat@wanadoo.fr
520    9_
$a Vascular calcifications (VCs) are frequently observed in chronic kidney disease (CKD) and haemodialysis (HD) patients. They have been associated with numerous factors, particularly hyperphosphataemia, excess calcium load, hypertension and increased mortality rate. The purpose of this study is to measure VCs in long-HD patients with good blood pressure and phosphate control, with the occasional use of sevelamer, using a plain radiological score to identify the associated factors and effects on the 1-year survival rate. METHODS: We studied HD patients from one centre using a semi-quantitative score ranging from 0 to 3 according to the severity and extent of VCs. The following patients' characteristics were compared according to their VC scores: medical history, treatments, blood pressure, standard biological data, fibroblast growth factor (FGF) 23, osteoprotegerin (OPG), whole PTH, beta-crosslaps, bone alkaline phosphatases and bone mineral density scores. One-year survival analyses were also performed. RESULTS: Among the 250 HD patients of the centre, 161 were studied; the mean age was 67.2 +/- 13 years, 45% of the subjects were females, 35% were diabetics, and they had been on dialysis for between 1-486 months (median: 45 months) with a 3 x 5-3 x 8 h dialysis schedule using 1.5 mmol/l dialysate calcium and providing a mean 2.25 +/- 0.5 Kt/V. Only 17% of the patients were free from VCs and 11% had severe VCs. The factors associated with VCs were classified into 'classic' (age, diabetes, male gender, tobacco use, inflammation, more frequent warfarin treatment and peripheral vascular and cardiac diseases) and 'non-traditional' (higher FGF-23 and OPG serum levels, low albumin serum levels and low alfacalcidol and CaCO(3) use). In logistic regression, only age, diabetes and FGF-23 serum levels were associated with VC scores of 2 and 3. The patients with a score of 3 had a higher 1-year mortality rate (RR 2.1; P = 0.01) as compared to patients with a 0 score. CONCLUSION: A plain radiological score showed the high prevalence (83%) of VCs in HD patients in spite of a long and intensive dialysis strategy and adherence to guidelines. The main associated factors were classic factors such as ageing and diabetes. No relationship was found with blood pressure and phosphataemia that remained well controlled in long dialysis; the association with FGF-23 serum levels may aggregate some non-traditional risk factors. The harmful effects of VCs on survival require their systematic assessment and optimization of the potentially modifiable associated factors in CKD and HD patients.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a kalcinóza $x epidemiologie $x radiografie $7 D002114
650    _2
$a chelátory $x terapeutické užití $7 D002614
650    _2
$a chronická nemoc $7 D002908
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a nemoci ledvin $x komplikace $x mortalita $x terapie $7 D007674
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a onemocnění periferních cév $x epidemiologie $x radiografie $7 D016491
650    _2
$a polyaminy $x terapeutické užití $7 D011073
650    _2
$a dialýza ledvin $7 D006435
650    _2
$a rizikové faktory $7 D012307
650    _2
$a míra přežití $7 D015996
700    1_
$a Bresson, E.
700    1_
$a Errat, J. C.
773    0_
$w MED00012709 $t Postgraduální nefrologie $g Roč. 7, č. 3 (2009), s. 38 $x 1214-178X
787    18
$w bmc07526717 $i Recenze v: $t Komentář [k článku Periferní vaskulární kalcifikace u hemodialyzovaných pacientů]
856    41
$u http://www.transplant.cz/vzdelavani/2009/09_03_04.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2318 $c 893 $y 9
990    __
$a 20090730080340 $b ABA008
991    __
$a 20090907120847 $b ABA008
999    __
$a ok $b bmc $g 670733 $s 529880
BAS    __
$a 3
BMC    __
$a 2009 $b 7 $c 3 $d 38 $i 1214-178X $m Postgraduální nefrologie $x MED00012709
LZP    __
$a 2009-25/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...